Aurora Cannabis Stock (CNSX:ACB) (OTC:ACBFF) - Investor Dashboard


Aurora Cannabis
TSX Venture Exchange: ACB
OTCQX Ticker: ACBFF
Sector: Healthcare
Industry: Legal Cannabis
Country: Canada
Employees: 140
Established: 2013
CEO: Terry Booth

Summary

Fiscal Year-End: June
License Renewal Month: February
Licenses: 1
Licensed Capacity: 5400 KG
Number of Patients: 16,000
Headquarters: Vancouver, BC

Financials (03/31/17)

Cash on hand: $111.1mm
Fixed Investment: $25.9mm
Shareholders’ Equity: $161.6mm
Revenues – Last Quarter: $5.2mm
Adj. Gross Margin: 60.7%
EPS : 0.00

Capital Structure (05/15/17)

Last Equity Financing: $75mm Convertible Notes at $3.29
Basic Shares: 355.2mm
Warrants: 24.5mm
Options: 17.5mm
Diluted Shares: 422.4mm

Company Brief

Aurora is one of 40+ licensed producers across Canada and one of two located in Alberta. Boasting the second highest square footage approved for production in Canada, Aurora was the first applicant in the Country to construct a purpose-built facility, which can now be described as no less than state-of-the-art. Because Alberta is one of the most business friendly provinces in the Country, Aurora is able to operate with lower overhead.

Located in rural Alberta there is no cost for the fresh mountain-fed water used in the facility, and operations take place under the lowest corporate tax rates and power rates in the Country. There is also an abundance of Alberta farm credit programs available to Aurora and a number of Albertan Innovation programs. Aurora is arguably the lowest cost-per-gram licensed producer in Canada.


Product Info

  • Most popular product: TEMPLE
  • 24 Strains used for both flower and oils
  • 10+ Flagship strains
    • THC %: < 1% – 32% (Highest reported)
    • CBD %: < 0.5% – 24% (Highest reported)
    • Types: Indica, Sativa, Hybird, Blend
  • 0 Pesticides and gamma-irradiation
  • $8 Per Gram; $5 / Gram Low Income Pricing
  • Oils now available

Growth Strategy

  • Customer experience
    • Differentiated Products
    • 24/7 client care support
    • Same day-delivery and weekend courier
    • Easy to use mobile app
  • Increase # of intermediary partners
  • Dispensary Transition Program
  • Aurora Wellness Centers
  • U.S. / International Expansion, including 19.9% ownership of Cann Group in Australia and ownership of German distributor Pedanios
  • Quebec expansion with acquisition of Peloton, a late-stage ACMPR

Differentiators

  • Purpose-built facility located on a low-cost, low-energy leased property with access to free water and room for expansion capable of serving 21K patients
  • Plans for state-of-the-art 800K sq. ft. fully automated greenhouse to be built in Alberta, Canada capable of producing 70mm grams per year
  • Only LP with tissue micro-propagation lab
  • Unique Temple strain with CBD tested at 24%
  • Ownership of CanvasRx, the largest operator of cannabis clinics in Canada
  • Same-day delivery in Alberta and innovative mobile ordering app
  • All products certified by third-party testing through Anandia Labs
  • 19.9% ownership of Australia’s Cann Group (ASX: CAN)
  • Ownership of German distribution company Pedanios

Institutional Analyst Coverage

NEIL MARUOKA
Canaccord

MARTIN LANDRY
GMP Securities

JASON ZANDBERG
PI Financial

GREG MCLEISH, CFA
Mackie Research


Curated Stories & News


Visit Aurora Cannabis
at www.auroramj.com.

New Cannabis Ventures in partnership with due diligence platform 420Investor, is the definitive source for fact-based, data-driven, financial information and relevant company news for qualified publicly traded cannabis companies. NCV extracts and parses only the most important content. Information is provided “as is” and solely for informational purposes, not for trading or advice. Aurora Cannabis is a client of NCV Media, LLC. Read our full disclaimer.